ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pneumococcal Vaccine - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-37E406
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pneumococcal Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Pneumococcal Vaccine - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-37E406
Report
November 2023
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
GSK
MSD
Sanofipasteur
CDIBP

Pneumococcal Vaccine - Market Size

The global Pneumococcal Vaccine market size is expected to reach US$ 7780.4 million by 2029, growing at a CAGR of 1.1% from 2023 to 2029.

Pneumococcal Vaccine - Market

Pneumococcal Vaccine - Market

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
The market is mainly driven by the significant applications of Pneumococcal Vaccine in various end use industries. The expanding demands from the Child and Adult, are propelling Pneumococcal Vaccine market. PPSV 23, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PCV 7/13 segment is estimated at % CAGR for the next seven-year period.
At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by End User. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pneumococcal Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Pneumococcal Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pneumococcal Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pneumococcal Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pneumococcal Vaccine covered in this report include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc.
The global Pneumococcal Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP

Scope of Pneumococcal Vaccine - Market Report

Report Metric Details
Report Name Pneumococcal Vaccine - Market
Forecasted market size in 2029 US$ 7780.4 million
CAGR 1.1%
Forecasted years 2023 - 2029
Global Pneumococcal Vaccine market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pneumococcal Vaccine market, Segment by Type:
  • PPSV 23
  • PCV 7/13
  • PCV 10
Global Pneumococcal Vaccine market, by End User
  • Child
  • Adult
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by End User, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Pneumococcal Vaccine - Market size in 2029?

Ans: The Pneumococcal Vaccine - Market size in 2029 will be US$ 7780.4 million.

What are the Type segmentation covered in the Pneumococcal Vaccine - Market report?

Ans: The Types covered in the Pneumococcal Vaccine - Market report are PPSV 23, PCV 7/13, PCV 10

What are the End User segmentation covered in the Pneumococcal Vaccine - Market report?

Ans: The End users covered in the Pneumococcal Vaccine - Market report are Child, Adult

1 Pneumococcal Vaccine Market Overview
1.1 Pneumococcal Vaccine Product Overview
1.2 Pneumococcal Vaccine Market Segment by Type
1.2.1 PPSV 23
1.2.2 PCV 7/13
1.2.3 PCV 10
1.3 Global Pneumococcal Vaccine Market Size by Type
1.3.1 Global Pneumococcal Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Pneumococcal Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pneumococcal Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pneumococcal Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pneumococcal Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pneumococcal Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pneumococcal Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pneumococcal Vaccine Sales Breakdown by Type (2018-2023)
2 Global Pneumococcal Vaccine Market Competition by Company
2.1 Global Top Players by Pneumococcal Vaccine Sales (2018-2023)
2.2 Global Top Players by Pneumococcal Vaccine Revenue (2018-2023)
2.3 Global Top Players by Pneumococcal Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Pneumococcal Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pneumococcal Vaccine Market Competitive Situation and Trends
2.5.1 Pneumococcal Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pneumococcal Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Pneumococcal Vaccine Market
2.8 Key Manufacturers Pneumococcal Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pneumococcal Vaccine Status and Outlook by Region
3.1 Global Pneumococcal Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pneumococcal Vaccine Historic Market Size by Region
3.2.1 Global Pneumococcal Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Pneumococcal Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Pneumococcal Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pneumococcal Vaccine Forecasted Market Size by Region
3.3.1 Global Pneumococcal Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Pneumococcal Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Pneumococcal Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pneumococcal Vaccine by End User
4.1 Pneumococcal Vaccine Market Segment by End User
4.1.1 Child
4.1.2 Adult
4.2 Global Pneumococcal Vaccine Market Size by End User
4.2.1 Global Pneumococcal Vaccine Market Size Overview by End User (2018-2029)
4.2.2 Global Pneumococcal Vaccine Historic Market Size Review by End User (2018-2023)
4.2.3 Global Pneumococcal Vaccine Forecasted Market Size by End User (2024-2029)
4.3 Key Regions Market Size Segment by End User
4.3.1 North America Pneumococcal Vaccine Sales Breakdown by End User (2018-2023)
4.3.2 Europe Pneumococcal Vaccine Sales Breakdown by End User (2018-2023)
4.3.3 Asia-Pacific Pneumococcal Vaccine Sales Breakdown by End User (2018-2023)
4.3.4 Latin America Pneumococcal Vaccine Sales Breakdown by End User (2018-2023)
4.3.5 Middle East and Africa Pneumococcal Vaccine Sales Breakdown by End User (2018-2023)
5 North America Pneumococcal Vaccine by Country
5.1 North America Pneumococcal Vaccine Historic Market Size by Country
5.1.1 North America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pneumococcal Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Pneumococcal Vaccine Sales in Value by Country (2018-2023)
5.2 North America Pneumococcal Vaccine Forecasted Market Size by Country
5.2.1 North America Pneumococcal Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Pneumococcal Vaccine Sales in Value by Country (2024-2029)
6 Europe Pneumococcal Vaccine by Country
6.1 Europe Pneumococcal Vaccine Historic Market Size by Country
6.1.1 Europe Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pneumococcal Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Pneumococcal Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Pneumococcal Vaccine Forecasted Market Size by Country
6.2.1 Europe Pneumococcal Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Pneumococcal Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Pneumococcal Vaccine by Region
7.1 Asia-Pacific Pneumococcal Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pneumococcal Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pneumococcal Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pneumococcal Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Pneumococcal Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pneumococcal Vaccine Sales in Value by Region (2024-2029)
8 Latin America Pneumococcal Vaccine by Country
8.1 Latin America Pneumococcal Vaccine Historic Market Size by Country
8.1.1 Latin America Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pneumococcal Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pneumococcal Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Pneumococcal Vaccine Forecasted Market Size by Country
8.2.1 Latin America Pneumococcal Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pneumococcal Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Pneumococcal Vaccine by Country
9.1 Middle East and Africa Pneumococcal Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pneumococcal Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pneumococcal Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pneumococcal Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Pneumococcal Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pneumococcal Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Pneumococcal Vaccine Products Offered
10.1.5 Pfizer Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Pneumococcal Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 MSD
10.3.1 MSD Company Information
10.3.2 MSD Introduction and Business Overview
10.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 MSD Pneumococcal Vaccine Products Offered
10.3.5 MSD Recent Development
10.4 Sanofipasteur
10.4.1 Sanofipasteur Company Information
10.4.2 Sanofipasteur Introduction and Business Overview
10.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofipasteur Pneumococcal Vaccine Products Offered
10.4.5 Sanofipasteur Recent Development
10.5 CDIBP
10.5.1 CDIBP Company Information
10.5.2 CDIBP Introduction and Business Overview
10.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CDIBP Pneumococcal Vaccine Products Offered
10.5.5 CDIBP Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pneumococcal Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pneumococcal Vaccine Industrial Chain Analysis
11.4 Pneumococcal Vaccine Market Dynamics
11.4.1 Pneumococcal Vaccine Industry Trends
11.4.2 Pneumococcal Vaccine Market Drivers
11.4.3 Pneumococcal Vaccine Market Challenges
11.4.4 Pneumococcal Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pneumococcal Vaccine Distributors
12.3 Pneumococcal Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
GSK
MSD
Sanofipasteur
CDIBP
List of Tables
    Table 1. Major Company of PPSV 23
    Table 2. Major Company of PCV 7/13
    Table 3. Major Company of PCV 10
    Table 4. Global Pneumococcal Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Pneumococcal Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 6. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global Pneumococcal Vaccine Sales by Type (2018-2023) & (US& Million)
    Table 8. Global Pneumococcal Vaccine Market Share in Value by Type (2018-2023)
    Table 9. Global Pneumococcal Vaccine Price by Type (2018-2023) & (USD/Dose)
    Table 10. Global Pneumococcal Vaccine Sales by Type (2024-2029) & (K Doses)
    Table 11. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global Pneumococcal Vaccine Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global Pneumococcal Vaccine Sales Market Share in Value by Type (2024-2029)
    Table 14. Global Pneumococcal Vaccine Price by Type (2024-2029) & (USD/Dose)
    Table 15. North America Pneumococcal Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 16. North America Pneumococcal Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe Pneumococcal Vaccine Sales (K Doses) by Type (2018-2023)
    Table 18. Europe Pneumococcal Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific Pneumococcal Vaccine Sales (K Doses) by Type (2018-2023)
    Table 20. Asia-Pacific Pneumococcal Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America Pneumococcal Vaccine Sales (K Doses) by Type (2018-2023)
    Table 22. Latin America Pneumococcal Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa Pneumococcal Vaccine Sales (K Doses) by Type (2018-2023)
    Table 24. Middle East and Africa Pneumococcal Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global Pneumococcal Vaccine Sales by Company (2018-2023) & (K Doses)
    Table 26. Global Pneumococcal Vaccine Sales Share by Company (2018-2023)
    Table 27. Global Pneumococcal Vaccine Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global Pneumococcal Vaccine Revenue Share by Company (2018-2023)
    Table 29. Global Market Pneumococcal Vaccine Price by Company (2018-2023) & (USD/Dose)
    Table 30. Global Pneumococcal Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global Pneumococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2022)
    Table 33. Date of Key Manufacturers Enter into Pneumococcal Vaccine Market
    Table 34. Key Manufacturers Pneumococcal Vaccine Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global Pneumococcal Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global Pneumococcal Vaccine Sales by Region (2018-2023) & (K Doses)
    Table 38. Global Pneumococcal Vaccine Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global Pneumococcal Vaccine Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global Pneumococcal Vaccine Sales Market Share in Value by Region (2018-2023)
    Table 41. Global Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 42. Global Pneumococcal Vaccine Sales by Region (2024-2029) & (K Doses)
    Table 43. Global Pneumococcal Vaccine Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global Pneumococcal Vaccine Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global Pneumococcal Vaccine Sales Market Share in Value by Region (2024-2029)
    Table 46. Global Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2029)
    Table 47. Global Pneumococcal Vaccine Sales by End User: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global Pneumococcal Vaccine Sales by End User (2018-2023) & (K Doses)
    Table 49. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2018-2023)
    Table 50. Global Pneumococcal Vaccine Sales by End User (2018-2023) & (US$ Million)
    Table 51. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2018-2023)
    Table 52. Global Pneumococcal Vaccine Price by End User (2018-2023) & (USD/Dose)
    Table 53. Global Pneumococcal Vaccine Sales by End User (2024-2029) & (K Doses)
    Table 54. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2024-2029)
    Table 55. Global Pneumococcal Vaccine Sales by End User (2024-2029) & (US$ Million)
    Table 56. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2024-2029)
    Table 57. Global Pneumococcal Vaccine Price by End User (2024-2029) & (USD/Dose)
    Table 58. North America Pneumococcal Vaccine Sales by End User (2018-2023) (K Doses)
    Table 59. North America Pneumococcal Vaccine Sales by End User (2018-2023) & (US$ Million)
    Table 60. Europe Pneumococcal Vaccine Sales by End User (2018-2023) (K Doses)
    Table 61. Europe Pneumococcal Vaccine Sales by End User (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific Pneumococcal Vaccine Sales by End User (2018-2023) (K Doses)
    Table 63. Asia-Pacific Pneumococcal Vaccine Sales by End User (2018-2023) & (US$ Million)
    Table 64. Latin America Pneumococcal Vaccine Sales by End User (2018-2023) (K Doses)
    Table 65. Latin America Pneumococcal Vaccine Sales by End User (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa Pneumococcal Vaccine Sales by End User (2018-2023) (K Doses)
    Table 67. Middle East and Africa Pneumococcal Vaccine Sales by End User (2018-2023) & (US$ Million)
    Table 68. North America Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
    Table 69. North America Pneumococcal Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America Pneumococcal Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America Pneumococcal Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 72. North America Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
    Table 73. North America Pneumococcal Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America Pneumococcal Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America Pneumococcal Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
    Table 77. Europe Pneumococcal Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe Pneumococcal Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe Pneumococcal Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
    Table 81. Europe Pneumococcal Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe Pneumococcal Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe Pneumococcal Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific Pneumococcal Vaccine Sales by Region (2018-2023) & (K Doses)
    Table 85. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific Pneumococcal Vaccine Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific Pneumococcal Vaccine Sales by Region (2024-2029) & (K Doses)
    Table 89. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific Pneumococcal Vaccine Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
    Table 93. Latin America Pneumococcal Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America Pneumococcal Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Pneumococcal Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
    Table 97. Latin America Pneumococcal Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America Pneumococcal Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America Pneumococcal Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
    Table 101. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa Pneumococcal Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
    Table 105. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa Pneumococcal Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 108. Pfizer Company Information
    Table 109. Pfizer Introduction and Business Overview
    Table 110. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 111. Pfizer Pneumococcal Vaccine Product
    Table 112. Pfizer Recent Development
    Table 113. GSK Company Information
    Table 114. GSK Introduction and Business Overview
    Table 115. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 116. GSK Pneumococcal Vaccine Product
    Table 117. GSK Recent Development
    Table 118. MSD Company Information
    Table 119. MSD Introduction and Business Overview
    Table 120. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 121. MSD Pneumococcal Vaccine Product
    Table 122. MSD Recent Development
    Table 123. Sanofipasteur Company Information
    Table 124. Sanofipasteur Introduction and Business Overview
    Table 125. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 126. Sanofipasteur Pneumococcal Vaccine Product
    Table 127. Sanofipasteur Recent Development
    Table 128. CDIBP Company Information
    Table 129. CDIBP Introduction and Business Overview
    Table 130. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
    Table 131. CDIBP Pneumococcal Vaccine Product
    Table 132. CDIBP Recent Development
    Table 133. Key Raw Materials Lists
    Table 134. Raw Materials Key Suppliers Lists
    Table 135. Pneumococcal Vaccine Market Trends
    Table 136. Pneumococcal Vaccine Market Drivers
    Table 137. Pneumococcal Vaccine Market Challenges
    Table 138. Pneumococcal Vaccine Market Restraints
    Table 139. Pneumococcal Vaccine Distributors List
    Table 140. Pneumococcal Vaccine Downstream Customers
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pneumococcal Vaccine Product Picture
    Figure 2. Global Pneumococcal Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Pneumococcal Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Pneumococcal Vaccine Sales Status and Outlook (2018-2029) & (K Doses)
    Figure 5. Product Picture of PPSV 23
    Figure 6. Global PPSV 23 Sales YoY Growth (2018-2029) & (K Doses)
    Figure 7. Product Picture of PCV 7/13
    Figure 8. Global PCV 7/13 Sales YoY Growth (2018-2029) & (K Doses)
    Figure 9. Product Picture of PCV 10
    Figure 10. Global PCV 10 Sales YoY Growth (2018-2029) & (K Doses)
    Figure 11. Global Pneumococcal Vaccine Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global Pneumococcal Vaccine Sales Market Share by Type in 2022 & 2029
    Figure 13. North America Pneumococcal Vaccine Sales Market Share in Volume by Type in 2022
    Figure 14. North America Pneumococcal Vaccine Sales Market Share in Value by Type in 2022
    Figure 15. Europe Pneumococcal Vaccine Sales Market Share in Volume by Type in 2022
    Figure 16. Europe Pneumococcal Vaccine Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Value by Type in 2022
    Figure 19. Latin America Pneumococcal Vaccine Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America Pneumococcal Vaccine Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Pneumococcal Vaccine Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Pneumococcal Vaccine Revenue in 2022
    Figure 25. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of Child
    Figure 27. Global Child Sales YoY Growth (2018-2029) & (K Doses)
    Figure 28. Product Picture of Adult
    Figure 29. Global Adult Sales YoY Growth (2018-2029) & (K Doses)
    Figure 30. Global Pneumococcal Vaccine Sales by End User (2018-2029) & (US$ Million)
    Figure 31. Global Pneumococcal Vaccine Sales Market Share by End User in 2022 & 2029
    Figure 32. North America Pneumococcal Vaccine Sales Market Share in Volume by End User in 2022
    Figure 33. North America Pneumococcal Vaccine Sales Market Share in Value by End User in 2022
    Figure 34. Europe Pneumococcal Vaccine Sales Market Share in Volume by End User in 2022
    Figure 35. Europe Pneumococcal Vaccine Sales Market Share in Value by End User in 2022
    Figure 36. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Volume by End User in 2022
    Figure 37. Asia-Pacific Pneumococcal Vaccine Sales Market Share in Value by End User in 2022
    Figure 38. Latin America Pneumococcal Vaccine Sales Market Share in Volume by End User in 2022
    Figure 39. Latin America Pneumococcal Vaccine Sales Market Share in Value by End User in 2022
    Figure 40. Middle East and Africa Pneumococcal Vaccine Sales Market Share in Value by End User in 2022
    Figure 41. Key Raw Materials Price
    Figure 42. Pneumococcal Vaccine Manufacturing Cost Structure
    Figure 43. Pneumococcal Vaccine Industrial Chain Analysis
    Figure 44. Channels of Distribution
    Figure 45. Distributors Profiles
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions